CVS HEALTH CORPORATION Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
CVS HEALTH CORPORATION (CVS) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-16.
Discontinued › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2021-02-16
- CVS HEALTH CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2020 was $0.00.
- CVS HEALTH CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2019 was $0.00.
- CVS HEALTH CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2018 was -$4.00M, a 500.00% decline from fiscal 2017.
- CVS HEALTH CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2017 was $1.00M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-02-16 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-16 |
| 2018-12-31 | -$4.00M 10-K · filed 2021-02-16 |
| 2017-12-31 | $1.00M 10-K · filed 2020-02-18 |
| 2016-12-31 | $2.00M 8-K · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |